Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Croce

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Bulletin Du Cancer|April 16, 2023
[Uterin sarcoma, high-grade stroma, indifferenciated, referential]Cyril Roussel-Simonin, Sabrina Croce, Frédéric Guyon, et al.
Bulletin Du Cancer|May 18, 2023
[Uterin adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group]Andy Karabajakian, Catherine Genestie, Pierre Meeus, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlationsSabrina Croce, Isabelle Hostein, Agnes Ribeiro, et al.
Annales De Pathologie|June 10, 2008
[Internal quality control of histological diagnosis in pathology. A nine-year experience]Sabrina Croce-Kleinmann, Luc Marcellin, Agnès Neuville, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2014
Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subsetArnold-Jan Kruse, Sabrina Croce, Roy F P M Kruitwagen, et al.
The American Journal of Surgical Pathology|September 10, 2020
Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell TumorsPauline Baillard, Catherine Genestie, Sabrina Croce, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2025
The MEF2D::NCOA2 Fusion Defines a Distinct Emerging Vulvovaginal Myxoid Epithelioid Tumor With Smooth Muscle DifferentiationAlexis Trecourt, Guillaume Bataillon, François Le Loarer, et al.
The American Journal of Surgical Pathology|July 3, 2015
SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomasMarie Karanian-Philippe, Valérie Velasco, Michel Longy, et al.
The American Journal of Surgical Pathology|June 23, 2020
Inflammatory Myofibroblastic Tumor of the Uterus: An Immunohistochemical Study of 23 CasesJennifer A Bennett, Sabrina Croce, Anna Pesci, et al.
Histopathology|October 29, 2020
p53 immunohistochemical analysis of fusion-positive uterine sarcomasNissreen Mohammad, Colin J R Stewart, Sarah Chiang, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Bulletin Du Cancer|April 16, 2023
[Uterin sarcoma, high-grade stroma, indifferenciated, referential]Cyril Roussel-Simonin, Sabrina Croce, Frédéric Guyon, et al.
Bulletin Du Cancer|May 18, 2023
[Uterin adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group]Andy Karabajakian, Catherine Genestie, Pierre Meeus, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlationsSabrina Croce, Isabelle Hostein, Agnes Ribeiro, et al.
Annales De Pathologie|June 10, 2008
[Internal quality control of histological diagnosis in pathology. A nine-year experience]Sabrina Croce-Kleinmann, Luc Marcellin, Agnès Neuville, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2014
Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subsetArnold-Jan Kruse, Sabrina Croce, Roy F P M Kruitwagen, et al.
The American Journal of Surgical Pathology|September 10, 2020
Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell TumorsPauline Baillard, Catherine Genestie, Sabrina Croce, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2025
The MEF2D::NCOA2 Fusion Defines a Distinct Emerging Vulvovaginal Myxoid Epithelioid Tumor With Smooth Muscle DifferentiationAlexis Trecourt, Guillaume Bataillon, François Le Loarer, et al.
The American Journal of Surgical Pathology|July 3, 2015
SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomasMarie Karanian-Philippe, Valérie Velasco, Michel Longy, et al.
The American Journal of Surgical Pathology|June 23, 2020
Inflammatory Myofibroblastic Tumor of the Uterus: An Immunohistochemical Study of 23 CasesJennifer A Bennett, Sabrina Croce, Anna Pesci, et al.
Histopathology|October 29, 2020
p53 immunohistochemical analysis of fusion-positive uterine sarcomasNissreen Mohammad, Colin J R Stewart, Sarah Chiang, et al.
Pageof 10